Sign in

You're signed outSign in or to get full access.

John S. Alphin

Director at PYXUS INTERNATIONAL
Board

About John S. Alphin

Independent director since January 2023 (age 51). Founder and Principal of JSAlphinConsulting LLC (since July 2022) and previously President of Alphin Insurance, LLC; earlier spent 24 years at British American Tobacco, most recently serving as Head of Global Leaf Sourcing (Sep 2015–Dec 2021), with prior senior roles including Brazil Head of Agri-Exports and Head of Global Supplier Management . His background provides the Board with expertise in global supply chains, tobacco/agricultural industry dynamics, strategy, operational efficiencies, and sustainability program implementation .

Past Roles

OrganizationRoleTenureCommittees/Impact
British American TobaccoHead of Global Leaf SourcingSep 2015–Dec 2021 Led global sourcing; supply chain, procurement, and sustainability expertise
British American TobaccoBrazil Head of Agri-Exports; Head of Global Supplier ManagementNot specified Senior roles across sourcing and supplier management
Alphin Insurance, LLCPresidentPrior to/and noted March 2024 Operated retail insurance agency; small/mid-sized business focus

External Roles

OrganizationRoleTenure
JSAlphinConsulting LLCFounder & PrincipalSince July 2022
Alphin Insurance, LLCFounder/PresidentSince March 2024 (and previously)

Board Governance

  • Committee assignments: Member, ESGN Committee; not on Audit or Compensation .
  • Committee chair roles: None; ESGN chaired by Cynthia P. Moehring; Audit chaired by Robert D. George; Compensation chaired by Patrick J. Bartels .
  • Committee meetings FY2025: Audit 8; Compensation 4; ESGN 4 .
  • Independence: Board determined Alphin is independent under NYSE rules; non-independent nominees are Sikkel, Ashton, and Bartels .
  • Attendance and engagement: Board held five meetings in FY2025; no director attended fewer than 75% of aggregate Board and committee meetings on which they served; non-management directors meet in executive session, presided by Lead Independent Director Robert D. George .
  • Risk oversight: Audit Committee holds primary responsibility; Board integrates risk management into strategy and operations .

Fixed Compensation

ItemFY2025 AmountNotes
Fees Earned or Paid in Cash$125,000 Matches Board member retainer $115,000 + one committee membership $10,000
Annual Retainer ScheduleBoard Member: $115,000; Audit Chair: +$35,000; Other Committee Chair: +$25,000; Committee Member (Non-Chair): +$10,000 Paid quarterly; prorated for partial service

Performance Compensation

Equity ComponentFY2025 ValueKey Terms
Stock Awards (RSUs)$27,522 (grant date fair value) Annual director equity grants generally target $125,000 in value using $11.40 per-share valuation; awards payable in common stock and subject to service through next annual meeting, plus an additional Vesting Condition: earliest of March 31, 2031, Change in Control, or listing of common stock on a registered exchange; Vesting Condition not satisfied as of proxy date
  • Performance metrics: No performance-based metrics disclosed for director equity (no EBITDA/TSR/ESG conditions); RSUs are time-based and contingent on corporate events/listing/CoC triggers .
  • Options: No option awards disclosed for directors .

Other Directorships & Interlocks

CompanyRoleNotes
None disclosedNo public company directorships for Alphin cited; investor-affiliated directors (Glendon/Monarch) serve on committees per governing documents, but Alphin is independent and not listed as investor-affiliated .

Expertise & Qualifications

  • Deep tobacco and agricultural industry experience; global sourcing, supplier management, and sustainability program leadership .
  • Strategic and operational consulting experience serving small/mid-sized enterprises .
  • Brings insights on complex global supply chains relevant to Pyxus .

Equity Ownership

As of DateShares Beneficially Owned% of ClassShares Outstanding
May 1, 202524,607,791
  • Hedging/pledging: Policies prohibit directors/executives from hedging or pledging company stock, including margin accounts and derivatives .
  • Ownership guidelines: Not disclosed for directors in proxy; annual RSU grants exist but remain unvested until long-dated/event-based Vesting Condition is met .

Governance Assessment

  • Committee effectiveness: Alphin serves on ESGN, which covers sustainability, stakeholder engagement, governance guidelines, director nominations, board evaluations, and succession oversight—aligned with his sustainability and supply chain background .
  • Independence and attendance: Independent under NYSE standards; met attendance threshold; participates in a Board with regular executive sessions and a designated Lead Independent Director .
  • Compensation alignment: Cash retainer reflects board and one committee role; equity grants exist but with atypical Vesting Condition requiring listing/CoC or 2031, which may limit near-term ownership alignment and create uncertainty around equity realization for independent directors .
  • Ownership signal: No reported beneficial ownership as of May 1, 2025—weak “skin in the game” signal; however, RSUs awarded are unvested due to Vesting Condition not yet met .
  • Related-party exposure: Proxy related-party disclosures focus on investor-affiliated funds (Glendon/Monarch/Owl Creek/CI) and a CEO family employment matter; Alphin is not named in related-party transactions—no conflicts identified in the filing for him .
  • Committee composition risk: Audit and Compensation committees include non-independent directors (Ashton/Bartels) given OTC listing and governing documents—potential governance quality concern versus exchange standards, though permissible under current listing status; Alphin is not on those committees .
  • Compliance: Section 16(a) reports for directors were timely filed—positive compliance signal .

RED FLAGS

  • Zero beneficial ownership reported as of May 1, 2025—limited alignment unless/until RSUs vest .
  • Unusual RSU Vesting Condition (earliest of 2031/Change in Control/listing), not satisfied as of proxy—equity alignment deferred and contingent on corporate events outside director performance .
  • Non-independent members on Audit and Compensation committees—elevated governance risk relative to typical exchange-listed standards .